# Chiral sensitivity of medetomidine lateral flow immunoassay test strips

**Authors:** Anita Amate, Marya Lieberman

PMC · DOI: 10.1186/s12954-025-01387-6 · Harm Reduction Journal · 2026-01-02

## TL;DR

This study examines how well medetomidine test strips detect different forms of the drug, finding that some strips only detect one version and may give false results.

## Contribution

The study is the first to evaluate the chiral sensitivity of medetomidine test strips across multiple lots and manufacturers.

## Key findings

- Some test strips only detect dexmedetomidine and not levomedetomidine.
- Certain strips require both enantiomers to produce a positive result.
- Xylazine does not cross-react, but detomidine HCl and levamisole can cause false positives.

## Abstract

Medetomidine has recently emerged in the illicit drug supply in the United States, and lateral flow immunoassay test strips are an inexpensive and easy-to-use field screening option for detecting this highly potent sedative. However, the drug is chiral, and the response of test strips to the different enantiomers has not been reported. This study evaluated the chiral sensitivity of 7 lots of medetomidine test strips produced by two manufacturers. Test strips were assessed using solutions of dexmedetomidine, levomedetomidine, and racemic medetomidine at varying concentrations, water types, and temperature conditions. Specificity was evaluated by testing structurally related compounds and other interferences. Multiple lots of medetomidine strips responded only to dexmedetomidine. These strips detect racemic medetomidine but give a negative result for pure levomedetomidine. Other lots of medetomidine strips required both dexmedetomidine and levomedetomidine to be present to give a positive result–either pure dexmedetomidine or pure levomedetomidine gave negative results. All strips performed best in 18 MΩ water. at temperatures of 25 °C or below. Xylazine did not cross-react. The veterinary sedative detomidine HCl caused false positives on all the strips at concentrations down to 0.07 mg/mL, and levamisole gave faint test lines (which can be misread as false positives) for almost all the strips at 2 mg/mL. Organizations selecting test strips for public health applications should select strips that can detect both dexmedetomidine and racemic versions of this sedative.

The online version contains supplementary material available at 10.1186/s12954-025-01387-6.

## Linked entities

- **Chemicals:** medetomidine (PubChem CID 60612), dexmedetomidine (PubChem CID 5311068), levomedetomidine (PubChem CID 60612), xylazine (PubChem CID 5707), detomidine HCl (PubChem CID 56031), levamisole (PubChem CID 26879)

## Full-text entities

- **Chemicals:** Medetomidine (MESH:D020926), dexmedetomidine (MESH:D020927), detomidine HCl (MESH:C041255), Xylazine (MESH:D014991), levamisole (MESH:D007978), water (MESH:D014867)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12866554/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12866554/full.md

## References

4 references — full list in the complete paper: https://tomesphere.com/paper/PMC12866554/full.md

---
Source: https://tomesphere.com/paper/PMC12866554